A carregar...
Overview and Management of Cardiac Adverse Events Associated With Tyrosine Kinase Inhibitors
BACKGROUND. Small-molecule tyrosine kinase inhibitors (TKIs) may provide an effective therapeutic option in patients with hematologic malignancies and solid tumors. However, cardiovascular (CV) events, including hypertension, heart failure, left ventricular systolic dysfunction, and QT prolongation,...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3755926/ https://ncbi.nlm.nih.gov/pubmed/23918069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0466 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|